Tag: Novartis

Novartis Announces Ambitious ESG Targets to Increase Access to Medicines and Achieve Full Carbon Neutrality

Stuart Mitchell

Novartis hosted a virtual investor event to provide a comprehensive overview of the company’s progress in its Environmental, Social and Governance (ESG) strategy. “ESG is a key strategic priority for the Novartis Board and Executive Committee and we made progress in all of our key ESG strategic pillars,” said Joerg Reinhardt, Chairman of Novartis. “Moving forward, we are further reinforcing the way we measure our impact with a set of new ESG targets, increasing our ambition to drive more value for society.” Novartis focuses on 4 key strategic ESG pillars…

Read More

Five nonprofit organizations to receive up to $250,000 through Novartis STEP Program™ to support sickle cell patient initiatives

Stuart Mitchell

Novartis has announced that five nonprofit organizations will receive a total of nearly $250,000 in funding through the company’s STEP (Solutions to Empower Patients) Program™. Now in its second year, the STEP Program supports nonprofit organizations by funding innovative programs that empower patients with significant unmet needs to navigate a path to better care. This year’s focus is on addressing some of the most pressing issues in the sickle cell disease (SCD) community. “People with sickle cell disease continue to face significant gaps in care which can be detrimental to…

Read More